IL129135A0 - 3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds - Google Patents

3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds

Info

Publication number: IL129135A0
Authority: IL; Israel
Prior art keywords: alkoxyisoxazol; substituted; carboxylic acid; acid compounds; amino carboxylic
Prior art date: 1996-10-04

Application number

IL12913597A

Other languages

English (en)

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-04

Filing date

1997-10-03

Publication date

2000-02-17

1997-10-03 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2000-02-17 Publication of IL129135A0 publication Critical patent/IL129135A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

IL12913597A 1996-10-04 1997-10-03 3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds IL129135A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK109296		1996-10-04
PCT/DK1997/000426 WO1998015542A1 (en)	1996-10-04	1997-10-03	3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds

Publications (1)

Publication Number	Publication Date
IL129135A0 true IL129135A0 (en)	2000-02-17

Family

ID=8100908

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12913597A IL129135A0 (en)	1996-10-04	1997-10-03	3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds

Country Status (26)

Country	Link
US (1)	US6200999B1 (is)
EP (1)	EP0934286B1 (is)
JP (1)	JP2001501630A (is)
KR (1)	KR20000048908A (is)
CN (1)	CN1238766A (is)
AR (1)	AR008880A1 (is)
AT (1)	ATE230734T1 (is)
AU (1)	AU733004B2 (is)
BG (1)	BG103348A (is)
BR (1)	BR9712198A (is)
CA (1)	CA2268028C (is)
CZ (1)	CZ116899A3 (is)
DE (1)	DE69718338T2 (is)
EA (1)	EA001625B1 (is)
ES (1)	ES2189978T3 (is)
HU (1)	HUP0000084A3 (is)
IL (1)	IL129135A0 (is)
IS (1)	IS5009A (is)
NO (1)	NO312961B1 (is)
NZ (1)	NZ334798A (is)
PL (1)	PL332553A1 (is)
SK (1)	SK42899A3 (is)
TR (1)	TR199900724T2 (is)
UA (1)	UA52698C2 (is)
WO (1)	WO1998015542A1 (is)
ZA (1)	ZA978877B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA73749C2 (en) *	1999-11-01	2005-09-15		Diarylenines
JP4052573B2 (ja)	2000-09-15	2008-02-27	バーテックスファーマシューティカルズインコーポレイテッド	イソオキサゾールおよびｅｒｋのインヒビターとしてのその使用
US20040106794A1 (en) *	2001-04-16	2004-06-03	Schering Corporation	3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
UA78529C2 (en)	2001-10-10	2007-04-10	Wyeth Corp	Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain
US20040152694A1 (en) *	2003-02-04	2004-08-05	Istvan Kurucz	Methods and compositions for treating inflammatory disorders of the airways
PT1611144E (pt)	2003-04-09	2010-11-12	Wyeth Llc	Derivados do ácido 2-(8,9-dioxo-2,6-diazabiciclo(5.2.0)- non-1(7)-eno-2-il)-alquil-fosfónico e sua utilização como antagonistas do receptor n-metil-d-aspartato (nmda)
TW200514775A (en)	2003-10-22	2005-05-01	Wyeth Corp	Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof
EP1937674A1 (en) *	2005-10-11	2008-07-02	F.Hoffmann-La Roche Ag	Isoxazole derivatives
US8722714B2 (en)	2008-01-16	2014-05-13	The Honk Kong University of Science and Technology	Oxazolidine derivatives as NMDA antagonists
EP2338492A1 (en)	2009-12-24	2011-06-29	Universidad del Pais Vasco	Methods and compositions for the treatment of alzheimer
TW201609719A (zh) *	2014-05-28	2016-03-16	美國禮來大藥廠	作為ＴＡＲＰ－γ８依賴性ＡＭＰＡ受體拮抗劑之６－經取代－３Ｈ－１，３－苯并噻唑－２－酮化合物
KR102157528B1 (ko)	2016-01-21	2020-09-21	아구로카네쇼 가부시키가이샤	2-아미노니코틴산 벤질에스테르 유도체의 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE108448T1 (de)	1990-05-11	1994-07-15	Sankyo Co	Piperdinyloxy- und chinindidinyloxy- isoxazol- derivate, ihre herstellung und ihre therapeutische verwendung.
AU678186B2 (en)	1992-10-23	1997-05-22	Merck Sharp & Dohme Limited	Dopamine receptor subtype ligands
DK124393D0 (da) *	1993-11-03	1993-11-03	Lundbeck & Co As H	Compounds

1997
- 1997-03-10 UA UA99042300A patent/UA52698C2/uk unknown
- 1997-10-03 JP JP10517096A patent/JP2001501630A/ja active Pending
- 1997-10-03 ZA ZA9708877A patent/ZA978877B/xx unknown
- 1997-10-03 KR KR1019990702938A patent/KR20000048908A/ko not_active Ceased
- 1997-10-03 HU HU0000084A patent/HUP0000084A3/hu unknown
- 1997-10-03 PL PL97332553A patent/PL332553A1/xx unknown
- 1997-10-03 CZ CZ991168A patent/CZ116899A3/cs unknown
- 1997-10-03 IL IL12913597A patent/IL129135A0/xx unknown
- 1997-10-03 TR TR1999/00724T patent/TR199900724T2/xx unknown
- 1997-10-03 NZ NZ334798A patent/NZ334798A/en unknown
- 1997-10-03 EP EP97942821A patent/EP0934286B1/en not_active Expired - Lifetime
- 1997-10-03 AT AT97942821T patent/ATE230734T1/de not_active IP Right Cessation
- 1997-10-03 ES ES97942821T patent/ES2189978T3/es not_active Expired - Lifetime
- 1997-10-03 AR ARP970104586A patent/AR008880A1/es not_active Application Discontinuation
- 1997-10-03 BR BR9712198-3A patent/BR9712198A/pt unknown
- 1997-10-03 DE DE69718338T patent/DE69718338T2/de not_active Expired - Fee Related
- 1997-10-03 WO PCT/DK1997/000426 patent/WO1998015542A1/en not_active Ceased
- 1997-10-03 AU AU44517/97A patent/AU733004B2/en not_active Ceased
- 1997-10-03 CN CN97180167A patent/CN1238766A/zh active Pending
- 1997-10-03 US US09/269,356 patent/US6200999B1/en not_active Expired - Fee Related
- 1997-10-03 EA EA199900358A patent/EA001625B1/ru not_active IP Right Cessation
- 1997-10-03 CA CA002268028A patent/CA2268028C/en not_active Expired - Fee Related
- 1997-10-03 SK SK428-99A patent/SK42899A3/sk unknown
1999
- 1999-03-20 BG BG103348A patent/BG103348A/xx unknown
- 1999-03-23 IS IS5009A patent/IS5009A/is unknown
- 1999-03-30 NO NO19991561A patent/NO312961B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2268028A1 (en)	1998-04-16
HUP0000084A3 (en)	2001-12-28
NZ334798A (en)	2000-06-23
US6200999B1 (en)	2001-03-13
EA001625B1 (ru)	2001-06-25
SK42899A3 (en)	1999-08-06
KR20000048908A (ko)	2000-07-25
IS5009A (is)	1999-03-23
JP2001501630A (ja)	2001-02-06
HUP0000084A2 (hu)	2000-06-28
BR9712198A (pt)	1999-08-31
WO1998015542A1 (en)	1998-04-16
AU4451797A (en)	1998-05-05
EP0934286B1 (en)	2003-01-08
CN1238766A (zh)	1999-12-15
BG103348A (en)	1999-11-30
ATE230734T1 (de)	2003-01-15
UA52698C2 (uk)	2003-01-15
NO312961B1 (no)	2002-07-22
AR008880A1 (es)	2000-02-23
CZ116899A3 (cs)	1999-09-15
NO991561L (no)	1999-06-04
AU733004B2 (en)	2001-05-03
TR199900724T2 (xx)	1999-06-21
ES2189978T3 (es)	2003-07-16
NO991561D0 (no)	1999-03-30
EP0934286A1 (en)	1999-08-11
EA199900358A1 (ru)	1999-10-28
PL332553A1 (en)	1999-09-13
DE69718338T2 (de)	2003-10-16
ZA978877B (en)	1998-04-17
CA2268028C (en)	2003-03-18
DE69718338D1 (de)	2003-02-13

Publication	Publication Date	Title
GB9626637D0 (en)	1997-02-12	Percarboxyilic acid solutions
HU9801045D0 (en)	1998-07-28	Substituted diamino-carboxylic acids
HUP0003881A3 (en)	2001-04-28	Amidocarboxylic acid derivatives
HUP9902645A3 (en)	1999-12-28	Fused-ring carboxylic acid derivatives
HUP0600401A3 (en)	2010-05-28	Naphtyridine carboxylic acid derivative salt
EP0801644A4 (en)	2001-03-07	POLYARYLCARBAMOYLAZADIOQUE ACIDS AND CARBAMOYLALCANEDIO QUES
ZA9810298B (en)	1999-05-18	Isothiazole carboxylic acid derivatives
NZ286622A (en)	1997-08-22	Fluorophenylalkenylcarboxylic acid guanidides
IL129135A0 (en)	2000-02-17	3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds
HU9500728D0 (en)	1995-04-28	5-vinyl- and 5-ethinyl-quinolon- and -naphtiridone-carboxylig acids
EP0774965A4 (en)	1997-10-29	PHENOXYPHENYLACETIC ACID DERIVATIVES
ZA948631B (en)	1995-07-10	5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
HU9503309D0 (en)	1996-01-29	Carboxylic acid amide benzothiophene-s-oxides
IL135967A (en)	2005-05-17	Jasmonic acid compounds and process for the preparation thereof
HU9700148D0 (en)	1997-03-28	Trifluoromethylquinolinecarboxylic acid derivative
ZA981472B (en)	1998-08-19	Process for the manufacture of carboxylic acids
GR3030629T3 (en)	1999-10-29	Clavulanic acid salts
ZA9510888B (en)	1996-06-24	3-aryl-tetronic acid derivatives
HUP9802329A3 (en)	1999-04-28	Carboxylic acid derivatives
IL135639A0 (en)	2001-05-20	Novel methylenebisphosphonic acid derivatives
SI0934286T1 (en)	2003-06-30	3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
ZA956017B (en)	1996-03-19	Heterocyclyl-1-phenyl-substituted quinolonecarboxylic acids
AU5319898A (en)	1998-06-10	Glyoxylic acid amides
ZA955966B (en)	1996-02-21	New N1-miscellaneous 6-fluoro-8-difluoromethoxy-substituted quinolonecarboxylic acids
AU8214498A (en)	1999-01-04	Glyoxylic acid amides